Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles

Pancreatic adenocarcinoma (PDAC) is a disease with a high incidence and a dreary prognosis. Its lack of symptomatology and late diagnosis contribute to the dearth and inefficiency of therapeutic schemes. Studies show that overexpressed epidermal growth factor receptor (EGFR) is a common occurrence,...

Descripción completa

Detalles Bibliográficos
Autores principales: Grapa, Cristiana Maria, Mocan, Teodora, Gonciar, Diana, Zdrehus, Claudiu, Mosteanu, Ofelia, Pop, Teodora, Mocan, Lucian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910098/
https://www.ncbi.nlm.nih.gov/pubmed/31849462
http://dx.doi.org/10.2147/IJN.S226628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6910098/
https://www.ncbi.nlm.nih.gov/pubmed/31849462
http://dx.doi.org/10.2147/IJN.S226628

Ejemplares similares